Anumana Named to Fast Company’s 2026 Most Innovative Companies Awards

The Real Test for AI Diagnostics Isn’t Performance — It’s Clinical Adoption

March 16, 2026

Cardiology, in particular, offers a clear view into why so many AI solutions struggle to scale and what differentiates those that are poised for adoption. Across healthcare, AI-enabled diagnostic solutions are flooding the market. From cardiology and imaging to oncology and primary care, clinicians are being asked to evaluate algorithms that promise earlier detection, better accuracy, and more efficient care. Many of these tools are technically impressive. Some are FDA-cleared. A few even come with early clinical data. Yet only a relatively small number have become part of routine clinical practice.

Read more on medcitynews.com

Share
Related Articles